Comments
Loading...
Gain Therapeutics (GANX) Forecast
NewsEarningsGain Therapeutics (GANX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGain Therapeutics (NASDAQ:GANX) Stock Quotes, Forecast and News Summary
Gain Therapeutics Stock (NASDAQ: GANX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gain Therapeutics (GANX) stock?
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Who are Gain Therapeutics (GANX) competitors?
Other companies in Gain Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Gain Therapeutics (GANX) stock?
Gain Therapeutics has a consensus price target of $7.88.
What is the current price for Gain Therapeutics (GANX)?
The stock price for Gain Therapeutics (NASDAQ: GANX) is $1.96 last updated December 30, 2024 at 12:07 PM EST.
Does Gain Therapeutics (GANX) pay a dividend?
There are no upcoming dividends for Gain Therapeutics.
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
Is Gain Therapeutics (GANX) going to split?
There is no upcoming split for Gain Therapeutics.
What sector and industry does Gain Therapeutics (GANX) operate in?
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.